Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995, 96: 1897-904.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lesske J, Fletcher EC, Bao G, Unger T: Hypertension caused by chronic intermittent hypoxia – influence of chemoreceptors and sympathetic nervous system. J Hypertens. 1997, 15: 1593-603. 10.1097/00004872-199715120-00060.
Article
CAS
PubMed
Google Scholar
Narkiewicz K, Somers VK: Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand. 2003, 177: 385-90. 10.1046/j.1365-201X.2003.01091.x.
Article
CAS
PubMed
Google Scholar
Börgel J, Sanner BM, Keskin F, Bittlinsky A, Bartels NK, Büchner N, Huesing A, Rump LC, Mügge A: Obstructive sleep apnea and blood Pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens. 2004, 17: 1081-1087. 10.1016/j.amjhyper.2004.06.026.
Article
PubMed
Google Scholar
Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000, 342: 1378-84. 10.1056/NEJM200005113421901.
Article
CAS
PubMed
Google Scholar
Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF: Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol. 2001, 154: 50-9. 10.1093/aje/154.1.50.
Article
CAS
PubMed
Google Scholar
Börgel J, Sanner BM, Bittlinsky A, Keskin F, Bartels NK, Büchner N, Huesing A, Rump LC, Mugge A: Obstructive sleep apnoea and its therapy influence high density lipoprotein cholesterol serum levels. Eur Respir J. 2006, 27: 121-127. 10.1183/09031936.06.00131304.
Article
PubMed
Google Scholar
Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O'Connor GT, Boland LL, Schwartz JE, Samet JM: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001, 163: 19-25.
Article
CAS
PubMed
Google Scholar
Marin J, Carrizo S, Vicente E, Agusti A: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005, 365: 1046-1053.
Article
PubMed
Google Scholar
Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, Rubin AH: Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep. 1995, 18: 149-57.
CAS
PubMed
Google Scholar
Liggett SB: Beta(2)-adrenergic receptor pharmacogenetics. Am J Respir Crit Care Med. 2000, 161: 197-201.
Article
Google Scholar
McGraw DW, Forbes SL, Kramer LA, Liggett SB: Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest. 1998, 102: 1927-32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnatty SE, Abdellatif M, Shimmin L, Clark RB, Boerwinkle E: Beta 2 adrenergic receptor 5' haplotypes influence promoter activity. Br J Pharmacol. 2002, 137: 1213-6. 10.1038/sj.bjp.0704935.
Article
CAS
PubMed
PubMed Central
Google Scholar
Green SA, Turki J, Innis M, Liggett SB: Amino-terminal polymorphisms of the human beta2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry. 1994, 33: 9414-9. 10.1021/bi00198a006.
Article
CAS
PubMed
Google Scholar
Kim SH, Kim DJ, Seo IA, Min YK, Lee MS, Kim KW, Lee MK: Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism. 2002, 51: 833-7. 10.1053/meta.2002.33347.
Article
CAS
PubMed
Google Scholar
Isaza C, Henao J, Ramirez E, Cuesta F, Cacabelos R: Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-relateted propanolol-induced dyslipidemia in the Colombian population. Methods Find Exp Clin Pharmacol. 2005, 27: 237-244. 10.1358/mf.2005.27.4.893582.
Article
CAS
PubMed
Google Scholar
Krushkal J, Ferrell R, Mockrin S, Turner ST, Sing CF, Boerwinkle E: Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation. 1999, 99: 1407-1410.
Article
CAS
PubMed
Google Scholar
Rankinen T, An P, Rice T, Sun G, Chagnon YC, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Rao DC, et al: Genomic scan for exercise blood pressure in the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Hypertension. 2001, 38: 30-37.
Article
CAS
PubMed
Google Scholar
Tomaszewski M, Brain NJ, Charchar FJ, Wang WY, Lacka B, Padmanabahn S, Clark JS, Anderson NH, Edwards HV, Zukowska-Szczechowska E, et al: Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis. Hypertension. 2002, 40: 286-91. 10.1161/01.HYP.0000029105.21202.FE.
Article
CAS
PubMed
Google Scholar
Ranade K, Shue WH, Hung YJ, Hsuing CA, Chiang FT, Pesich R, Hebert J, Olivier M, Chen YD, Pratt R, et al: The glycine allele of a glycine/arginine polymorphism in the beta2-adrenergic receptor gene is associated with essential hypertension in a population of Chinese origin. Am J Hypertens. 2001, 14: 1196-200. 10.1016/S0895-7061(01)02213-0.
Article
CAS
PubMed
Google Scholar
Ge D, Huang J, He J, Li B, Duan X, Chen R, Gu D: β2-Adrenergic receptor gene variations associated with stage-2 hypertension in Northern Han Chinese. Ann Hum Genet. 2005, 69: 36-44. 10.1046/j.1529-8817.2003.00093.x.
Article
CAS
PubMed
Google Scholar
Bengtsson K, Orho-Melander M, Melander O, Lindblad U, Ranstam J, Rastam L, Groop L: Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension. 2001, 37: 1303-8.
Article
CAS
PubMed
Google Scholar
Hindorff LA, Heckbert SR, Psaty BM, Lumley T, Siscovick DS, Herrington DM, Edwards KL, Tracy RP: β2-adrenergic receptor polymorphisms and determinants of cardiovascular risk: The Cardiovascular Health Study. Am J Hypertens. 2005, 18: 392-397. 10.1016/j.amjhyper.2004.10.014.
Article
CAS
PubMed
Google Scholar
Heckbert SR, Hindorff LA, Edwards KL, Psaty BM, Lumley T, Siscovick DS, Tang Z, Durda JP, Kronmal RA, Tracy RP: Beta2-adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation. 2003, 107: 2021-4. 10.1161/01.CIR.0000065231.07729.92.
Article
CAS
PubMed
Google Scholar
Sotoodehnia N, Sicovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA, Lemaitre RN, Rea TD, Durda JP, Chang JM, et al: Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation. 2006, 113: 1818-1820. 10.1161/CIRCULATIONAHA.105.582833.
Article
Google Scholar
Albert CM, Mittleman MD, Chae CU, Lee IM, Hennekens CH, Manson JE: Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med. 2000, 343: 1355-1361. 10.1056/NEJM200011093431902.
Article
CAS
PubMed
Google Scholar
Joos L, Weir TD, Connett JE, Anthonisen NR, Woods R, Pare PD, Sandford AJ: Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax. 2003, 58: 703-7. 10.1136/thorax.58.8.703.
Article
CAS
PubMed
PubMed Central
Google Scholar
Beckmann L, Bronnestam R, Cedergren B, Liden S: HL-A antigens, blood groups, serum groups and red cell enzyme thypes in psoriasis. Hum Hered. 1974, 24: 496-506.
Article
Google Scholar
Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, Bouvier M: A Peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem. 1996, 271: 16384-16392. 10.1074/jbc.271.24.14280.
Article
CAS
PubMed
Google Scholar
Hebert TE, Loisel TP, Adam L, Ethier N, Onge SS, Bouvier M: Functional rescue of a constitutively desensitized beta2AR through receptor dimerization. Biochem J. 1998, 15: 287-293.
Article
Google Scholar